WEBULL

A Look At Lantheus Holdings (LNTH) Valuation After Recent Short Term Share Price Momentum

Simply Wall St · 6d ago

Lantheus Holdings (LNTH) has recently caught investor attention after its shares closed at $67.27, with returns over the past month and the past 3 months contrasting with a weaker 1 year total return profile.

See our latest analysis for Lantheus Holdings.

That recent 29.76% 3 month share price return contrasts with a weaker 1 year total shareholder return of 28.30% decline, suggesting shorter term momentum has picked up even as longer term holders are still under water.

If Lantheus has caught your eye, this could be a good moment to widen your watchlist across healthcare stocks that may offer different risk and growth profiles within the sector.

With shares at $67.27, a value score of 4, an intrinsic discount of 57.53% and a 23.60% gap to analyst targets, investors may question whether Lantheus is still undervalued or whether the market is already pricing in future growth.

Most Popular Narrative: 18.2% Undervalued

Compared with the last close at $67.27, the most widely followed narrative sees Lantheus shares trading below an implied fair value of about $82.29, based on a discounted cash flow framework that uses a 7.99% discount rate and updated assumptions for growth and profitability.

“The analysts have a consensus price target of $89.5 for Lantheus Holdings based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $130.0, and the most bearish reporting a price target of just $63.0.”

Read the complete narrative.

Curious what kind of earnings ramp, margin profile, and valuation multiple need to line up to justify that higher fair value range? The narrative leans on a detailed earnings path, a richer profit margin outlook, and a future P/E that still sits below the broader industry. The full set of assumptions is where the story really gets interesting.

Result: Fair Value of $82.29 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story can quickly wobble if Pylarify pricing pressure deepens or new products under-deliver, which could challenge both revenue assumptions and the projected margin lift.

Find out about the key risks to this Lantheus Holdings narrative.

Build Your Own Lantheus Holdings Narrative

If you are not fully on board with this storyline or prefer to stress test the numbers yourself, you can build a fresh view in minutes, starting with Do it your way.

A great starting point for your Lantheus Holdings research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you are serious about building a stronger portfolio, do not stop at one company. Use the screener to uncover more ideas that fit your style.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.